Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $30.04-$78.48 |
Market Cap | $5.5B |
Shares Short | 21M |
Financials
See moreRevenue (12 Mos) | $38.3M |
Revenue Growth (YoY) | 47.7% |
Gross Profit (12 Mos) | -$430.6M |
Diluted EPS | -$5.54 |
News
See moreYahoo Finance • 10 days ago
Contrarius Global Equity Fund’s Thoughts on CRISPR Therapeutics’ (CRSP) Gene Editing Therapy
Yahoo Finance • 10 days ago
TSLA: Cathie Wood Dumps $30 Million Worth Tesla Stock
Yahoo Finance • 11 days ago
Cathie Wood invests heavily in gene-editing companies, offloads $30 million worth Tesla stock
Yahoo Finance • 13 days ago
Cathie Wood Bets Big On Self-Driving and Gene-Editing Stocks Ahead of 2026
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
